Entrada Therapeutics (TRDA) Institutional Ownership

$17.22

+0.12 (+0.70%)

(As of 07/26/2024 ET)

Current Institutional Ownership Percentage: 86.39%
Number of Institutional Buyers (last 12 months): 11
Total Institutional Inflows (last 12 months): $3.24M

Number of Institutional Sellers (last 12 months): 9
Total Institutional Outflows (last 12 months): $9.80M

Get TRDA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TRDA Institutional Buying and Selling by Quarter

Ad American Hartford Gold Group

Prepare for a Recession Unlike Any Other

Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.

GET THE FREE GUIDE

Entrada Therapeutics Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Allspring Global Investments Holdings LLC	27,631	$394K	0.0%	+87.2%	0.082%
7/26/2024	Bank of New York Mellon Corp	125,436	$1.79M	0.0%	+13.4%	0.372%
5/16/2024	California State Teachers Retirement System	12,631	$179K	0.0%	-11.1%	0.037%
5/15/2024	Price T Rowe Associates Inc. MD	2,753,357	$39.02M	0.0%	-8.5%	8.156%
5/10/2024	Acadian Asset Management LLC	5,685	$79K	0.0%	N/A	0.017%
5/10/2024	Vanguard Group Inc.	1,078,908	$15.29M	0.0%	+1.3%	3.203%
Get the Latest News and Ratings for TRDA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
5/7/2024	SG Americas Securities LLC	7,687	$109K	0.0%	-34.4%	0.023%
4/30/2024	Allspring Global Investments Holdings LLC	14,763	$209K	0.0%	+427.6%	0.044%
4/25/2024	New York State Teachers Retirement System	1,915	$27K	0.0%	N/A	0.006%
4/18/2024	Allspring Global Investments Holdings LLC	14,763	$209K	0.0%	+427.6%	0.044%
3/5/2024	Wellington Management Group LLP	1,047,780	$15.81M	0.0%	+0.2%	3.140%
2/14/2024	72 Investment Holdings LLC	172,600	$2.61M	11.6%	-66.1%	0.517%
2/13/2024	Tower Research Capital LLC TRC	5,780	$87K	0.0%	+476.3%	0.017%
2/6/2024	Swiss National Bank	23,000	$347K	0.0%	-8.7%	0.069%
1/30/2024	Strs Ohio	24,100	$363K	0.0%	+792.6%	0.072%
1/12/2024	SG Americas Securities LLC	11,714	$177K	0.0%	+27.7%	0.035%
12/1/2023	Wellington Management Group LLP	1,045,652	$16.52M	0.0%	+2.6%	3.134%
11/15/2023	Redmile Group LLC	1,284,000	$20.29M	1.0%	-2.1%	3.848%
11/14/2023	Corton Capital Inc.	10,485	$166K	0.1%	-42.0%	0.031%
10/27/2023	Allspring Global Investments Holdings LLC	2,798	$44K	0.0%	N/A	0.008%
10/27/2023	TD Asset Management Inc	119,254	$1.88M	0.0%	+100.0%	0.359%
10/13/2023	SG Americas Securities LLC	9,174	$145K	0.0%	N/A	0.028%
9/21/2023	Barclays PLC	6,440	$97K	0.0%	-37.0%	0.019%
8/11/2023	Nan Fung Group Holdings Ltd	49,082	$743K	0.5%	-33.3%	0.148%
8/4/2023	American International Group Inc.	10,299	$156K	0.0%	N/A	0.031%
7/31/2023	Strs Ohio	2,700	$40K	0.0%	N/A	0.008%
5/11/2023	CHI Advisors LLC	56,374	$817K	0.2%	N/A	0.170%
5/9/2023	Y Intercept Hong Kong Ltd	10,188	$148K	0.0%	N/A	0.031%
2/14/2023	683 Capital Management LLC	10,355	$140K	0.0%	N/A	0.033%
2/9/2023	Citigroup Inc.	51,042	$690K	0.0%	+3,124.4%	0.163%
2/8/2023	Swiss National Bank	26,500	$358K	0.0%	N/A	0.084%
11/15/2022	TCG Crossover Management LLC	642,189	$10.12M	3.0%	-3.2%	2.045%
11/15/2022	Laurion Capital Management LP	199,066	$3.14M	0.0%	+54.2%	0.634%
11/10/2022	Nan Fung Group Holdings Ltd	141,593	$2.23M	1.4%	-18.4%	0.451%
11/7/2022	TD Asset Management Inc.	59,496	$925K	0.0%	+3.2%	0.189%
8/15/2022	Laurion Capital Management LP	129,066	$1.57M	0.0%	N/A	0.411%
5/27/2022	Walleye Capital LLC	44,652	$419K	0.0%	N/A	0.142%
5/5/2022	New York State Common Retirement Fund	4,880	$46K	0.0%	N/A	0.016%
2/18/2022	TCG Crossover Management LLC	663,694	$11.36M	5.3%	N/A	2.126%
2/14/2022	Redmile Group LLC	1,954,420	$33.46M	0.8%	N/A	6.262%
Heard about the 72-Hour Profit Surge? Read this… (Ad) One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details.
2/14/2022	72 Investment Holdings LLC	509,024	$8.71M	7.7%	N/A	1.631%
2/14/2022	Suvretta Capital Management LLC	106,000	$1.82M	0.0%	N/A	0.340%
2/14/2022	Ghisallo Capital Management LLC	15,000	$257K	0.0%	N/A	0.048%
2/14/2022	Goldman Sachs Group Inc.	7,626,182	$130.56M	0.0%	N/A	24.433%
2/11/2022	MPM Asset Management LLC	4,425,784	$75.77M	16.4%	N/A	14.179%
2/10/2022	TD Asset Management Inc.	57,675	$987K	0.0%	N/A	0.185%
2/8/2022	Northern Trust Corp	79,483	$1.36M	0.0%	N/A	0.255%
2/3/2022	5AM Venture Management LLC	4,408,379	$75.47M	14.2%	N/A	14.124%

(Data available from 1/1/2016 forward)

TRDA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TRDA shares?: During the previous two years, 26 institutional investors and hedge funds held shares of Entrada Therapeutics. The most heavily invested institutionals were Price T Rowe Associates Inc. MD ($39.02M), Redmile Group LLC ($20.29M), Wellington Management Group LLP ($15.81M), Vanguard Group Inc. ($15.29M), TCG Crossover Management LLC ($10.12M), Laurion Capital Management LP ($3.14M), and 72 Investment Holdings LLC ($2.61M).Learn more on TRDA's institutional investors.
What percentage of Entrada Therapeutics stock is owned by institutional investors?: 86.39% of Entrada Therapeutics stock is owned by institutional investors. Learn more on TRDA's institutional investor holdings.
Which institutional investors have been buying Entrada Therapeutics stock?: Of the 18 institutional investors that purchased Entrada Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Laurion Capital Management LP ($199.07K), TD Asset Management Inc ($59.63K), CHI Advisors LLC ($56.37K), Citigroup Inc. ($49.46K), Allspring Global Investments Holdings LLC ($39.60K), Wellington Management Group LLP ($28.27K), and Swiss National Bank ($26.50K).

How much institutional buying is happening at Entrada Therapeutics?: Institutional investors have bought a total of 568,328 shares in the last 24 months. This purchase volume represents approximately $8.08M in transactions.
Which Entrada Therapeutics major shareholders have been selling company stock?: Of the 10 institutional investors that sold Entrada Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: 72 Investment Holdings LLC ($336.42K), Price T Rowe Associates Inc. MD ($256.32K), Nan Fung Group Holdings Ltd ($56.49K), Redmile Group LLC ($27.57K), TCG Crossover Management LLC ($21.51K), Corton Capital Inc. ($7.58K), and SG Americas Securities LLC ($4.03K).
How much institutional selling is happening at Entrada Therapeutics?: Institutional investors have sold a total of 717,481 shares in the last 24 months. This volume of shares sold represents approximately $10.65M in transactions.